YUHSpace: Dept. of Obstetrics and Gynecology (산부인과학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Obstetrics and Gynecology (산부인과학교실)

Dept. of Obstetrics and Gynecology (산부인과학교실)

Researcher List

Keyword Cloud

Journal Categories

Hot Articles

MicroRNA expression profiles in serous ovarian carcinoma

Eun Ji Nam ; Heejei Yoon ; Sang Wun Kim ; Hoguen Kim ; Young Tae Kim ; Jae Ho... CLINICAL CANCER RESEARCH, Vol.14(9) : 2690-2695, 2008

HanByoul Cho ; Hye Won Hur ; Sang Wun Kim ; Sung Hoon Kim ; Jae Hoon Kim ; Yo... CANCER IMMUNOLOGY IMMUNOTHERAPY, Vol.58(1) : 15-23, 2009

Osteopontin as apotential diagnostic biomarker for ovarian cancer

Jae Hoon Kim ; Steven J. Skates ; Toshimitsu Uede ; Kwong Kwok Wong ; John O.... JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, Vol.287(13) : 1671-1679, 2002

This table browses all dspace content
Issue Date	Title	Journal Title
2022	Prognostic value of circulating tumor DNA (ctDNA) in ovarian cancer	ANNALS OF ONCOLOGY
2022	Spinal Versus General Anesthesia for Cesarean Delivery in Pregnant Women With Moyamoya Disease: A Retrospective Observational Study	ANESTHESIA AND ANALGESIA
2022	Response to letter to editor: indocyanine green fluorescent image-guided inguinal sentinel node biopsy for vulvar cancer: criteria and intraoperative challenges	Obstetrics & Gynecology Science
2022	Risk of obstetric and neonatal morbidity in gestational diabetes in a single institution: A retrospective, observational study	MEDICINE
2022	Sentinel lymph node biopsy in high-risk endometrial cancer: performance, outcomes, and future avenues	Obstetrics & Gynecology Science
2022	Efficacy and safety of GX-188E, a therapeutic DNA vaccine, combined with pembrolizumab in HPV 16- and/or 18- positive advanced cervical cancer (phase II): Safe and effective in both PD-L1 positive and negative	ANNALS OF ONCOLOGY
2022	Genomic DNA analysis of cervical smear samples of endometrial cancer with next-generation sequencing: A prospective study	ANNALS OF ONCOLOGY
2022	Feasibility of longitudinal monitoring of whole blood-based circulating tumour DNA (ctDNA) in patients with endometrial cancer	ANNALS OF ONCOLOGY
2022	Usefulness and potential pitfalls of pre-operative PET-CT in patients with endometrial cancer undergoing one- and two-step sentinel lymph node mapping: Do negative findings on PET-CT negativity really indicate node negativity?	GYNECOLOGIC ONCOLOGY
2022	Feasibility and clinical applicability of genomic profiling based on cervical smear samples in patients with endometrial cancer	FRONTIERS IN ONCOLOGY
2022	Effects of sarcopenia and sarcopenic obesity on joint pain and degenerative osteoarthritis in postmenopausal women	SCIENTIFIC REPORTS
2022	Prenatal Diagnosis of Congenital Heart Diseases and Associations with Serum Biomarkers of Aneuploidy: A Multicenter Prospective Cohort Study	YONSEI MEDICAL JOURNAL
2022	A Predictive Model for Large-for-Gestational-Age Infants among Korean Women with Gestational Diabetes Mellitus Using Maternal Characteristics and Fetal Biometric Parameters	JOURNAL OF CLINICAL MEDICINE
2022	Predicting preterm birth through vaginal microbiota, cervical length, and WBC using a machine learning model	FRONTIERS IN MICROBIOLOGY
2022	Interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in advanced-stage ovarian cancer: Single-institution cohort study	FRONTIERS IN ONCOLOGY
2022	Identification of Lynch Syndrome in Patients with Endometrial Cancer Based on a Germline Next Generation Sequencing Multigene Panel Test	CANCERS
2022	Overexpression of glucocorticoid receptor promotes the poor progression and induces cisplatin resistance through p38 MAP kinase in cervical cancer patients	AMERICAN JOURNAL OF CANCER RESEARCH
2022	Etiology and Secular Trends in Primary Amenorrhea in 856 Patients: A 17-Year Retrospective Multicenter Study in Korea	JOURNAL OF KOREAN MEDICAL SCIENCE
2022	Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial	JOURNAL OF GYNECOLOGIC ONCOLOGY
2022	A Phase II Trial to Evaluate the Efficacy of Bortezomib and Liposomal Doxorubicin in Patients With BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer (KGOG 3044/EBLIN)	IN VIVO